Clinical Trials
6 trialsNCT02782546 2026-06-01
Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation
Washington University School of Medicine
Phase 2 Active not recruiting
NCT07355205 2026-05-22
FLINN
Washington University School of Medicine
Phase 2 Not yet recruiting
NCT02989844 2023-11-03
Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT
Masonic Cancer Center, University of Minnesota
Phase 2 Completed
NCT03050216 2023-07-18
QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
Masonic Cancer Center, University of Minnesota
Phase 2 Completed
NCT05007769 2021-11-05
RAN
Washington University School of Medicine
Phase 2 Withdrawn
NCT03003728 2020-07-10
2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)
University of Arkansas
Phase 2 Withdrawn